Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer
Authors:
- 29 July 2016
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 41 (1) , 258-266
Abstract
Background: The survival impact of distal pancreatectomy (DP) with celiac axis resection for locally advanced pancreatic body/tail cancer remains unclear.Methods: A total of 16 patients underwent DP with celiac axis resection, while 76 underwent standard DP for pancreatic body/tail cancer. The indications for DP with celiac axis resection included: (a) tumor invasion of either the celiac axis or common hepatic artery or both [CA/CHA (+)] and (b) tumor invasion of the root of the splenic artery, which is difficult to dissect without securing an adequate surgical margin [CA/CHA (−)].Results: DP with celiac axis resection presented longer operative time and greater amount of blood loss than DP. The median survival time was 17.5 months in the DP with celiac axis resection group and 43.1 months in the DP group (p = 0.040). Among the patients who underwent DP with celiac axis resection, the median survival time was 35.1 months in the CA/CHA (−) group and 13.2 months in the CA/CHA (+) group (p = 0.001). Comparing the patients undergoing standard DP and DP with celiac axis resection with a CA/CHA (−) status, there were no significant differences in either disease‐free or overall survival times. The CA19‐9 value, CA/CHA (+) status, and microscopic venous infiltration were revealed independent significant prognostic factors.Conclusions: DP with celiac axis resection should therefore be indicated in patients with a CA/CHA (−) status. However, it is difficult to justify the use of DP with celiac axis resection in patients with CA/CHA (+) status due to the poor survival.Keywords
This publication has 27 references indexed in Scilit:
- Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialThe Lancet Oncology, 2013
- Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: A Single-Center ExperienceAnnals of Surgical Oncology, 2010
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of DiseaseJournal of the American College of Surgeons, 2008
- En Bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood VesselsAnnals of Surgery, 2008
- Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic AdenocarcinomaAnnals of Surgery, 2007
- Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body CancerAnnals of Surgery, 2007
- A Margin-Negative R0 Resection Accomplished With Minimal Postoperative Complications Is the Surgeon's Contribution to Long-Term Survival in Pancreatic CancerJournal of Gastrointestinal Surgery, 2006
- Current standards of surgery for pancreatic cancerBritish Journal of Surgery, 2004
- Perineural invasion of carcinoma of the pancreas and biliary tractBritish Journal of Surgery, 1993
- The coeliac axis in the expansion of the operation for gastric carcinomaCancer, 1953